Sunshine Biopharma Inc. - Warrant (NQ: SBFMW )

0.1200 +0.0100 (+9.09%)

Streaming Delayed Price Updated: 9:30 AM EDT, Sep 13, 2024 Add to My Watchlist

Price and Volume

Volume	212
Open	0.1200
Bid (Size)	0.0750 (3)
Ask (Size)	0.2900 (10)
Prev. Close	0.1100
Today's Range	0.1200 - 0.1200
52wk Range	0.0360 - 0.3500
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Sunshine Biopharma Q2 Report Reveals Approximately 1,940% Increase In Cash & Cash Equivalents And 80% Decrease In Net Loss Within 6 Months

August 08, 2022

Sunshine Biopharma, Inc. (NASDAQ: SBFM) (NASDAQ: SBFMW) announced that it has filed its 2022 second-quarter report with the Securities and Exchange Commission.

Via Benzinga

Sunshine Biopharma Reveals Potential Intellectual Property Position In Connection With Ongoing mRNA-As-Therapeutics-Agents Research

April 26, 2022

Photo credit: Patent application by Nick Youngson CC BY-SA 3.0

Via Benzinga

Performance

YTD	-29.41%	-29.41%
1 Month	+26.32%	+26.32%
3 Month	+41.18%	+41.18%
6 Month	+110.90%	+110.90%
1 Year	-38.46%	-38.46%

More News

Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells

April 25, 2022

Via Benzinga

Sunshine Biopharma Sees Potential Multi-Billion Dollar Global Market Opportunity As Research Findings Reveal Effectiveness Against Multidrug-Resistant Cancer Cells

April 06, 2022

Via Benzinga

Sunshine Biopharma, Inc. Announces Pricing of $8 Million Private Placement Priced At-the-Market

March 14, 2022

Via Benzinga

Aegis Capital Corp. acted as Sole Bookrunner on an Uplist of an $8 Million Underwritten Public Offering for Sunshine Biopharma Inc. (NASDAQ: SBFM; SBFMW)

February 17, 2022

From Aegis Capital Corp.

Via AccessWire

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.